Xiaobing Chen

2.1k total citations · 1 hit paper
66 papers, 1.5k citations indexed

About

Xiaobing Chen is a scholar working on Molecular Biology, Cancer Research and Pulmonary and Respiratory Medicine. According to data from OpenAlex, Xiaobing Chen has authored 66 papers receiving a total of 1.5k indexed citations (citations by other indexed papers that have themselves been cited), including 41 papers in Molecular Biology, 25 papers in Cancer Research and 14 papers in Pulmonary and Respiratory Medicine. Recurrent topics in Xiaobing Chen's work include MicroRNA in disease regulation (17 papers), Circular RNAs in diseases (11 papers) and Cancer-related molecular mechanisms research (10 papers). Xiaobing Chen is often cited by papers focused on MicroRNA in disease regulation (17 papers), Circular RNAs in diseases (11 papers) and Cancer-related molecular mechanisms research (10 papers). Xiaobing Chen collaborates with scholars based in China, United States and Belgium. Xiaobing Chen's co-authors include Saiqi Wang, Minghua Hu, Xinguang Cao, Beibei Chen, Hong‐Min Liu, Hongping Xia, Weifeng Xu, Liangyu Bie, Honglin Liu and Qingjiang Chen and has published in prestigious journals such as Journal of Clinical Oncology, SHILAP Revista de lepidopterología and Journal of The Electrochemical Society.

In The Last Decade

Xiaobing Chen

64 papers receiving 1.5k citations

Hit Papers

Application and synthesis of thiazole ring in clinically ... 2023 2026 2024 2025 2023 25 50 75 100
What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

  1. Application and synthesis of thiazole ring in clinically approved drugs
    2023 109 citations Xiaobing Chen, Saiqi Wang et al. profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Xiaobing Chen China 24 991 643 330 147 131 66 1.5k
Xiaoping Qian China 19 527 0.5× 333 0.5× 324 1.0× 173 1.2× 110 0.8× 66 991
Yubin Mao China 18 1.1k 1.2× 502 0.8× 687 2.1× 111 0.8× 220 1.7× 23 2.0k
Lijuan Zhang China 19 1.1k 1.2× 709 1.1× 206 0.6× 117 0.8× 85 0.6× 68 1.5k
Ilaria Laurenzana Italy 22 962 1.0× 523 0.8× 180 0.5× 65 0.4× 170 1.3× 55 1.4k
Ning‐Fang Ma China 14 1.1k 1.1× 622 1.0× 325 1.0× 98 0.7× 135 1.0× 29 1.5k
Luca Pasquini Italy 22 1.1k 1.1× 577 0.9× 359 1.1× 161 1.1× 328 2.5× 40 1.6k
Mala Shanmugam United States 18 971 1.0× 511 0.8× 389 1.2× 75 0.5× 163 1.2× 42 1.4k
Kwang‐Yu Chang Taiwan 21 772 0.8× 393 0.6× 328 1.0× 207 1.4× 137 1.0× 58 1.3k
Cecilia Battistelli Italy 25 1.4k 1.4× 835 1.3× 209 0.6× 72 0.5× 143 1.1× 51 1.9k
Zhaojin Yu China 23 1.1k 1.1× 490 0.8× 532 1.6× 128 0.9× 286 2.2× 63 1.7k

Countries citing papers authored by Xiaobing Chen

Since Specialization
Citations

This map shows the geographic impact of Xiaobing Chen's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Xiaobing Chen with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Xiaobing Chen more than expected).

Fields of papers citing papers by Xiaobing Chen

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Xiaobing Chen. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Xiaobing Chen. The network helps show where Xiaobing Chen may publish in the future.

Co-authorship network of co-authors of Xiaobing Chen

This figure shows the co-authorship network connecting the top 25 collaborators of Xiaobing Chen. A scholar is included among the top collaborators of Xiaobing Chen based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Xiaobing Chen. Xiaobing Chen is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Xu, Weifeng, Caiyun Nie, Zhen Liu, et al.. (2025). Identification of molecular subtypes based on pseudouridine modification in hepatocellular carcinoma. Cancer Cell International. 25(1). 247–247. 1 indexed citations
2.
Dai, Xing‐Jie, Huimin Liu, Shaopeng Wang, et al.. (2024). Degraders in epigenetic therapy: PROTACs and beyond. Theranostics. 14(4). 1464–1499. 23 indexed citations
3.
4.
5.
6.
Xu, Weifeng, Caiyun Nie, & Xiaobing Chen. (2023). DUSP4 inhibits autophagic cell death and apoptosis in colorectal cancer by regulating BCL2-Beclin1/Bax signaling. Molecular Biology Reports. 50(4). 3229–3239. 8 indexed citations
7.
Mao, Zhihui, Qiang Chen, Zhongzheng Zhu, et al.. (2022). Multifunctional Peptides Modified Conductive Nano-Network Based on GO and Gold Nano Triangular: Sensitive Detection of PD-L1 Exosomes in Serum. Journal of The Electrochemical Society. 169(7). 76505–76505. 1 indexed citations
8.
Yang, Wei, et al.. (2022). Prognostic and Predictive Model of the Log Odds of the Negative Lymph Node/T Stage Ratio in Resectable Gastric Adenocarcinoma Patients. Journal of Gastrointestinal Surgery. 26(8). 1743–1756. 3 indexed citations
9.
Xu, Weifeng, Caiyun Nie, Huifang Lv, et al.. (2022). Molecular subtypes based on Wnt-signaling gene expression predict prognosis and tumor microenvironment in hepatocellular carcinoma. Frontiers in Immunology. 13. 1010554–1010554. 7 indexed citations
10.
Wang, Shuai, Saiqi Wang, Qiu‐Xu Teng, et al.. (2021). Discovery of the Triazolo[1,5-a]Pyrimidine-Based Derivative WS-898 as a Highly Efficacious and Orally Bioavailable ABCB1 Inhibitor Capable of Overcoming Multidrug Resistance. Journal of Medicinal Chemistry. 64(21). 16187–16204. 29 indexed citations
11.
Nie, Caiyun, Huifang Lv, Yingjun Liu, et al.. (2021). Clinical Study of Sintilimab as Second-Line or Above Therapy in Patients With Advanced or Metastatic Gastric Cancer: A Retrospective Study. Frontiers in Oncology. 11. 741865–741865. 5 indexed citations
12.
Wang, Shuai, Saiqi Wang, Qiu‐Xu Teng, et al.. (2020). Structure-Based Design, Synthesis, and Biological Evaluation of New Triazolo[1,5- a ]Pyrimidine Derivatives as Highly Potent and Orally Active ABCB1 Modulators. Journal of Medicinal Chemistry. 63(24). 15979–15996. 41 indexed citations
13.
Tian, Chen, Xiaobing Chen, Yan Li, et al.. (2019). Synaptic Kalirin-7 and Trio Interactomes Reveal a GEF Protein-Dependent Neuroligin-1 Mechanism of Action. Cell Reports. 29(10). 2944–2952.e5. 26 indexed citations
14.
15.
Song, Jingjing, Sijia Zhao, Juan Fang, et al.. (2016). Foxp3 overexpression in tumor cells predicts poor survival in oral squamous cell carcinoma. BMC Cancer. 16(1). 530–530. 38 indexed citations
16.
Fu, Qiang, Jing Cheng, Yonglei Zhang, et al.. (2016). miR-20b reduces 5-FU resistance by suppressing the ADAM9/EGFR signaling pathway in colon cancer. Oncology Reports. 37(1). 123–130. 50 indexed citations
17.
Wu, Wei, Rodrigo Juliani Siqueira Dalmolin, Ming Yan, et al.. (2015). Prediction of long noncoding RNA functions with co-expression network in esophageal squamous cell carcinoma. BMC Cancer. 15(1). 168–168. 54 indexed citations
18.
Chen, Xiaobing, Yongsheng Wang, Hongping Xia, et al.. (2012). Loss of E-cadherin promotes the growth, invasion and drug resistance of colorectal cancer cells and is associated with liver metastasis. Molecular Biology Reports. 39(6). 6707–6714. 70 indexed citations
19.
Chen, Tingting, et al.. (2012). A De-embedding Method of Measuring One-port Resonators. 34(3). 331–333.
20.
Hu, Minghua, et al.. (2009). MicroRNA-141 Regulates Smad Interacting Protein 1 (SIP1) and Inhibits Migration and Invasion of Colorectal Cancer Cells. Digestive Diseases and Sciences. 55(8). 2365–2372. 70 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Xiaoping Qian Breakdown of academic impact, for papers by Yubin Mao Breakdown of academic impact, for papers by Lijuan Zhang Breakdown of academic impact, for papers by Ilaria Laurenzana Breakdown of academic impact, for papers by Ning‐Fang Ma Breakdown of academic impact, for papers by Luca Pasquini Breakdown of academic impact, for papers by Mala Shanmugam Breakdown of academic impact, for papers by Kwang‐Yu Chang Breakdown of academic impact, for papers by Cecilia Battistelli Breakdown of academic impact, for papers by Zhaojin Yu
Rankless by CCL
2026